Top Markets
Coin of the day
4basebio PLC 4basebio PLC

4basebio PLC

4BB
Rank in Stocks #38174
4basebio PLC, an enterprise established in 2020 and situated in Cambridge,... 4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
Share Price
$7.48
Market Cap
$1.16M
Change (1 day)
4.76%
Change (1 year)
-38.53%
Country
GB
Trade 4basebio PLC (4BB)

Category

P/B ratio for 4basebio PLC (4BB)
P/B ratio as of 2026 TTM: 0
According to 4basebio PLC latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for 4basebio PLC from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE